Full Press Release Details
- Cowen 44 th Annual Healthcare Conference on March 5 - Leerink Partners Global Biopharma Conference on March 11 - Jefferies Biotech on the Bay Summit on March 12 - Barclays 26 th Annual Global Healthcare Conference on March 12
SAN RAFAEL, Calif. , March 1, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) today announced management is scheduled to participate in four upcoming investor conferences in March.
Cowen 44 th Annual Healthcare Conference ( Boston, MA )
Leerink Partners Global BioPharma Conference ( Miami, FL )
Jefferies Biotech on the Bay Summit ( Miami, FL )
Barclays 26 th Annual Global Healthcare Conference ( Miami, FL )
The live webcast of the fireside chat can be accessed by visiting BioMarin's website at https://investors.biomarin.com/ . A webcast replay will be available through the Company's website for a limited time following the conferences.
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com .
| Contacts: | |
| Investors | Media |
| Traci McCarty | Marni Kottle |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
| (415) 455-7558 | (650) 374-2803 |
SOURCE BioMarin Pharmaceutical Inc.